Michiko Togane

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes.

Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes.

Journal: Expert opinion on pharmacotherapy

Published: March 28, 2025

Phase Angle Evaluated by a Bioimpedance Analysis Is Closely Related to Diabetic Nephropathy and Peripheral Neuropathy in Patients with Type 2 Diabetes.

Phase Angle Evaluated by a Bioimpedance Analysis Is Closely Related to Diabetic Nephropathy and Peripheral Neuropathy in Patients with Type 2 Diabetes.

Journal: JMA journal

Published: February 12, 2025

Deterioration of the Defecation Status after Hospitalization in Patients with Type 2 Diabetes Is Associated with Albuminuria Rather Than Diabetic Neuropathy.

Deterioration of the Defecation Status after Hospitalization in Patients with Type 2 Diabetes Is Associated with Albuminuria Rather Than Diabetic Neuropathy.

Journal: Internal medicine (Tokyo, Japan)

Published: November 27, 2024

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes.

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes.

Journal: Journal of diabetes investigation

Published: November 13, 2024

Effect of Baseline Values of Renal Prognosis-related Factors on Their Changes after Initiating Tofogliflozin Treatment: A Retrospective Study in Japanese Patients with Type 2 Diabetes and Renal Impairment.

Effect of Baseline Values of Renal Prognosis-related Factors on Their Changes after Initiating Tofogliflozin Treatment: A Retrospective Study in Japanese Patients with Type 2 Diabetes and Renal Impairment.

Journal: JMA journal

Published: June 19, 2024

The change in Fibrosis-4 index in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide: A retrospective observational study.

The change in Fibrosis-4 index in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide: A retrospective observational study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 06, 2023

Relationship Between the Effect of Roxadustat and Comorbid Diabetes in Non-dialyzed Chronic Kidney Disease Patients: A Retrospective Observational Study.

Relationship Between the Effect of Roxadustat and Comorbid Diabetes in Non-dialyzed Chronic Kidney Disease Patients: A Retrospective Observational Study.

Journal: Cureus

Published: May 26, 2023

Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin.

Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin.

Journal: PloS one

Published: March 07, 2023

Anemia combined with albuminuria increases the risk of cardiovascular and renal events, regardless of a reduced glomerular filtration rate, in patients with type 2 diabetes: a prospective observational study.

Anemia combined with albuminuria increases the risk of cardiovascular and renal events, regardless of a reduced glomerular filtration rate, in patients with type 2 diabetes: a prospective observational study.

Journal: Diabetology international

Published: February 20, 2023

Constipation Is a Frequent Problem Associated with Vascular Complications in Patients with Type 2 Diabetes: A Cross-sectional Study.

Constipation Is a Frequent Problem Associated with Vascular Complications in Patients with Type 2 Diabetes: A Cross-sectional Study.

Journal: Internal medicine (Tokyo, Japan)

Published: May 01, 2022

Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control.

Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control.

Journal: Diabetology international

Published: February 03, 2021

Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.

Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.

Journal: PloS one

Published: January 05, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026